Regulatory product record

CANINSULIN

Approved veterinary drugDPD species: DogDPD species: Cat

Product identity, ingredients and source provenance from the regulatory catalogue. Linked clinical evidence has a separate review status.

Product identity

Brand name: CANINSULIN
DIN: 02052474
DPD drug code: 16466
Regulatory category: APPROVED_VET_DRUG
Market status: MARKETED
Route(s): SUBCUTANEOUS
Pharmaceutical form(s): SUSPENSION
Ingredients: INSULIN PORK (40 UNIT)
Species (DPD record): DOGS, CATS
Company: INTERVET CANADA CORP (DIN owner)

Source and provenance

Source dataset: health_canada_dpd_marketed
Source snapshot date: Not available in this source
Source record key: 16466
Archive fingerprint (SHA-256): 85cc3ce208af3aa57018c3d14d83f90220c436baef7455384b6d48d9774e1c88

Linked clinical reference

Clinical entries are linked through the active molecule. Check their species, formulation, source and review status separately from this product record.

Clinical evidence

Pending clinical review (PROPOSED)Rule-based (RULE_BASED)— applies to the facts and dose entries in this species selection; individual source records retain their own status.

Dose regimens1

This calculator performs arithmetic only on the sourced dosing field shown for each result — it does not verify the field's accuracy, does not select which field to use for a patient, and does not replace a veterinarian's order. Not for clinical use. Confirm every result against the primary source before dispensing.

Review the source route shown below.
Enter patient weight and its unit.
For volume, optionally enter a matching label concentration.

Source route: Route not specified

Patient weight (species not recorded, kg)

Patient weight stays in this browser tab only — it is never sent to the server, logged, or saved. Changing species or weight units clears weight and concentration; enter the new values before calculating.

Optional concentration (mg/mL) — verify against the label

mg/mL

Enter the product label concentration in mg/mL matching the same ingredient/combined dose basis and formulation as the source dose. No formulation is selected or verified by the platform. Species or weight-unit changes clear this field.

Manual verification required — this source did not state a per-weight dose this calculator can compute from.

Source regimen: Not available in this source
Source formulation
Not specified in this source
Dose basis
Not specified in this source
Indication: Not specified in this source field
Manual verification required — this source did not state a per-weight dose this calculator can compute from.
SPL section 34068-7 (DOSAGE & ADMINISTRATION SECTION)

Adverse effects48

These are counts of spontaneously reported events, not proven adverse effects, causal relationships, or incidence rates.

Bars compare report counts within each species; they do not show incidence.

More reportsFewer reports

Dog

INEFFECTIVE, GLYCEMIC CONTROL26 reports
INEFFECTIVE, LOSS OF EFFECT9 reports
Drug preparation error6 reports
Hypoglycaemia5 reports
Anorexia3 reports
Lack of efficacy - NOS3 reports
Lethargy (see also Central nervous system depression in Neurological)3 reports
Vocalisation3 reports
Weight loss3 reports
Decreased appetite2 reports
Drug dose administration interval too short2 reports
Abnormal urine odour1 reports

Cat

INEFFECTIVE, GLYCEMIC CONTROL5 reports
Vomiting2 reports
Death1 reports
Death by euthanasia1 reports
Lack of efficacy - NOS1 reports
Lethargy (see also Central nervous system depression in Neurological)1 reports
Overdose1 reports

Contraindications1

® ® Dogs and cats known to have a systemic allergy to pork or pork products should not be treated with vetsulin. vetsulinis contraindicated during periods of hypoglycemia.
Species not recordedOn-label (ON_LABEL)United States
1 source record · View provenance
- Species not recorded · SPL section 34070-3 (CONTRAINDICATIONS SECTION) · United States · On-label (ON_LABEL) · Pending clinical review (PROPOSED) · Rule-based

Precautions2

Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Species not recordedOn-label (ON_LABEL)United States
1 source record · View provenance
- Species not recorded · SPL section 42232-9 (PRECAUTIONS SECTION) · United States · On-label (ON_LABEL) · Pending clinical review (PROPOSED) · Rule-based
Animals presenting with severe ketoacidosis, anorexia, lethargy, and/or vomiting should be stabilized with short-acting insulin and appropriate supportive therapy until their condition is stabilized. As with all insulin products, careful patient monitoring for hypoglycemia and hyperglycemia are essential to attain and maintain adequate glycemic control and prevent associated complications. Overdosage can result in profound hypoglycemia and death. Progestogens, certain endocrinopathies, and glucocorticoids can have an antagonistic effect on insulin activity. Intact bitches should be ovariohysterectomized. Progestogen and glucocorticoid use should be avoided.
Species not recordedOn-label (ON_LABEL)United States
1 source record · View provenance
- Species not recorded · SPL section 42232-9 (PRECAUTIONS SECTION) · United States · On-label (ON_LABEL) · Pending clinical review (PROPOSED) · Rule-based

Sources: DailyMed, U.S. National Library of Medicine; openFDA, U.S. Food and Drug Administration.

Product identity

Linked clinical reference

Clinical evidence

Dose calculation

Dog

Cat